72 results
8-K
EX-4.1
o0md7v 8heu
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
hn3zuqnev 5mjqzn
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
ovy5wmza4sp ns01fmhm
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
ydejivunv8iieg fkisn
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-10.1
62a1prs6f4vy
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
07bgs
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-1.2
5x19rl fu0goul
9 Nov 22
Shelf registration
4:15pm